SurgerEase im Vergleich zu Shoulder Innovations Nutzung und Statistiken

SurgerEase is a simple and efficient mobile management application for surgical scheduling, patient management and care team coordination. SurgerEase dramatically increases efficiencies within the clinic and provides a HIPAA compliant solution for sharing case details with your Anesthesiologist, First Assist, Hospital, Surgery Center, Vendors, Surgeon and Staff. We make every step of the surgery procedure better with smart workflows, processes, and communication, offering a simple and efficient management tool that will change the way surgical cases are coordinated. Through a Shared Platform SurgerEase Automates: - Surgery Scheduling - Case Management - Careteam Coordination - Patient Communications SurgerEase streamlines the process of scheduling surgical cases and automates all of the time consuming communication with the care team and patient. We seamlessly coordinates all education, reminders, documents and case updates to the patient. A process that once took hours can now be completed in minutes. Try SurgerEase for free today.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

The InSet™ Total Shoulder System from Shoulder Innovations is the result of the collaboration between clinicians and design engineers searching for a novel approach to Anatomic Shoulder Arthroplasty. This App is designed to provide information and resources to our surgeons, customers, and team.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

SurgerEasevs. Shoulder Innovations Ranking-Vergleich

Vergleichen Sie SurgerEase den Ranking-Trend der letzten 28 Tage mit Shoulder Innovations

Rang

Keine Daten verfügbar

SurgerEase im Vergleich zu Shoulder Innovations Ranking im Ländervergleich

Vergleichen Sie SurgerEase den Ranking-Trend der letzten 28 Tage mit Shoulder Innovations

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
SurgerEase VS.
Shoulder Innovations

Januar 3, 2025